Replies to post #12574 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Exactly, valuation parity with ADRO is a $20 stock price on ADXS. We should be there at the very least. Let's see what catalyst Dan pulls out of his sleeve to get us there. Hopefully it's a big enough catalyst (i.e., major deal with upfront cash) that we won't see another post-deal dilution pushing the stock back down.